• Medical Information Documents

  • Recent Congress Data

  • On Demand Medical Videos

    • Congress Data

      The Use of Tivicay plus Epivir for Treatment-Naïve Adults with HIV-1

      GEMINI-1 and GEMINI-2 Studies
      Michael Aboud, VP, Global Medical Lead, Dolutegravir

      DTG: Metabolic Data Update

      Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

      Post-CROI 2021 Webinar

      Andrew Zolopa, MD, VP, Head, North America Medical Affairs
    • Clinical Trials Data

      The Use of Tivicay plus Epivir for Treatment-Naïve Adults with HIV-1

      GEMINI-1 and GEMINI-2 Studies
      Michael Aboud, VP, Global Medical Lead, Dolutegravir

      Post-CROI 2021 Webinar

      Andrew Zolopa, MD, VP, Head, North America Medical Affairs
    • Dosing

      Tivicay PD: An Option for Children Living with HIV

      Ana M. Puga, MD, Regional Medical Director
    • Pharmacokinetics

      Tivicay PD: An Option for Children Living with HIV

      Ana M. Puga, MD, Regional Medical Director
    • Safety

      Post-CROI 2021 Webinar

      Andrew Zolopa, MD, VP, Head, North America Medical Affairs

      DTG: Metabolic Data Update

      Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

      Antiretroviral Therapy and Weight Gain

      Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir
    • Data in Pediatrics

      Tivicay PD (Video)

    • Weight Gain

      Weight Gain (Video)

      Metabolic Health (Video)